Ledger.Open graph →
SEC Form D · Amendment · filed August 5, 2021

Aristea Therapeutics, Inc

Offering
$63.1M
Sold
$63.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Tiba Aynechi · San Diego, CADirectorKenneth Harrison · San Diego, CADirectorCiara Kennedy · San Diego, CADirectorJames Mackay · San Diego, CAExec · DirectorJoseph K. Cunningham · Sunrise, FLDirectorTroy P. Cunningham · Sunrise, FLExec · DirectorPhillip Weicker · Gardena, CADirectorJohn Harris · Gardena, CADirectorLoretta Tse · San Diego, CADirectorLauren Fundr Capital, Inc. Washington · Austin, TXExec · DirectorBradley Dillon · Littleton, CODirectorJohn Bruton · Dublin, IrelandDirectorJessica Eggins · Alpharetta, GADirectorLoretta Tse · San Diego, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗